PharmGen Science, Inc. (KRX: 004720)

Market Cap	76.45B
Revenue (ttm)	173.60B
Net Income (ttm)	-1.24B
Shares Out	18.14M
EPS (ttm)	-68.22
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50,590
Open	4,265.00
Previous Close	4,345.00
Day's Range	4,160.00 - 4,345.00
52-Week Range	3,970.00 - 6,850.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 20, 2025

About PharmGen Science

PharmGen Science, Inc. engages in the research and development, production, and sale of pharmaceutical products in South Korea. It provides prescription drugs, OTC drugs, diagnostic test kits, health and general foods, and cosmetics, as well as shampoo, conditioner, and hair oil products under the neomcell brand name. The company was formerly known as Wooridul Pharmaceutical Limited and changed its name to PharmGen Science, Inc. PharmGen Science, Inc. was founded in 1957 and is headquartered in Hwaseong-si, South Korea.

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1957
• Employees: 254
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 004720

Financial Performance

In 2023, PharmGen Science's revenue was 166.78 billion, an increase of 10.50% compared to the previous year's 150.93 billion. Earnings were 5.73 billion, a decrease of -91.83%.